Inflammation, immunomodulation, and metabolic targets in cardiogenic shock

21 March 2026 (12:12 - 12:24)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Alastair Proudfoot

Barts Heart Centre, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail

Precision medicine in cardiogenic shock: implications of patient phenotyping and endotyping for therapy selection

Doctor H. Soeholm (Lund, SE)

Presentation thumbnail

Mixed shock: from definition to management

Professor D. Morrow (Boston, US)

Presentation thumbnail

Building systems of care: from prehospital recognition to rescue therapies in the context of shock networks

Professor S. Price (London, GB)

Presentation thumbnail

Next frontiers in cardiogenic shock: from bench to bedside - discussion

Access the full session

Session thumbnail

Next frontiers in cardiogenic shock: from bench to bedside

The Event

Event poster

ESC Acute CardioVascular Care 2026

21 March 2026 12:12 CET

You may be interested in

Congress Presentation

Novel agents in cardiogenic shock

Congress Presentation

Peripheral drivers: inflammation, gut-liver axis, and endotoxemia in acute heart failure-coronary syndrome

Congress Presentation

Targeting inflammation: a new frontier in managing cardiogenic shock?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources